Skip to main content
. 2011 Jul 1;96(7):963–971. doi: 10.3324/haematol.2010.039669

Figure 2.

Figure 2.

Denaturating gradient cell electrophoresis and sequencing analysis of DNA from bone marrow cells isolated before (week 1) and after treatment with lenalidomide (week 16). In patient SW16 (A) the relative amount of TP53 mutant cells (R175H) increased after treatment, while in patient SW23 (B) the mutant clone (E258D) was reduced by lenalidomide.